The mechanism of everolimus inhibiting deterioration of renal function is not well known but it is hypothesized that mTOR activation may be the reason for decline of renal function in TSC patients, therefore early intervention with mTOR inhibitors may be beneficial in preserving renal function (25). This evidence concerns the gene MTOR and tuberous sclerosis.